Valneva SE (VALN) Gross Profit (2021 - 2026)
Valneva SE's (VALN) quarterly Gross Profit came in at $5.1 million in Q1 2026, down 81.11% year-on-year from $26.9 million in Q1 2025, and up 79.58% quarter-over-quarter from $2.8 million in Q4 2025.
Valneva SE (VALN) Gross Profit (2021 - 2026) Analysis & Trends
Valneva SE has disclosed Gross Profit across 6 years of filings, most recently posting $5.1 million for Q1 2026.
- Gross Profit for Q1 2026 came in at $5.1 million, down 81.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $33.9 million (down 60.67% YoY), and the FY2025 annual result was $59.1 million, down 14.62% from the prior year.
- Gross Profit came in at $5.1 million for Q1 2026 at Valneva SE, up from $2.8 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $26.9 million in Q1 2025 to a low of -$149.9 million in Q2 2022.
- The 5-year median for Gross Profit is $10.9 million (2024), against an average of -$1.9 million.
- Across the five-year window, Gross Profit plunged 2671.57% in 2022 and surged 382.74% in 2023, its largest moves.
- Valneva SE's Gross Profit stood at -$83.0 million in 2022, then jumped by 127.9% to $23.2 million in 2023, then increased by 8.78% to $25.2 million in 2024, then tumbled by 88.77% to $2.8 million in 2025, then jumped by 79.58% to $5.1 million in 2026.
- The last three Gross Profit figures came in at $5.1 million (Q1 2026), $2.8 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.08 Mn |
| Mar 31, 2026 | 5.08 Mn |
| Dec 31, 2025 | 2.83 Mn |
| Dec 31, 2025 | 2.83 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Jun 30, 2025 | 20.72 Mn |
| Jun 30, 2025 | 20.72 Mn |
| Mar 31, 2025 | 26.88 Mn |
| Mar 31, 2025 | 26.88 Mn |
| Dec 31, 2024 | 25.18 Mn |
| Dec 31, 2024 | 25.18 Mn |
| Sep 30, 2024 | 20.36 Mn |
| Sep 30, 2024 | 20.36 Mn |
| Jun 30, 2024 | 13.64 Mn |
| Jun 30, 2024 | 13.64 Mn |
| Mar 31, 2024 | 10.85 Mn |
| Mar 31, 2024 | 10.85 Mn |
| Dec 31, 2023 | 23.15 Mn |
| Dec 31, 2023 | 23.15 Mn |